Altering Sedation Paradigms to Improve Brain Injury and Survival in Severe Sepsis
Phase of Trial: Phase III
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Dexmedetomidine (Primary) ; Propofol (Primary)
- Indications Delirium
- Focus Biomarker; Therapeutic Use
- Acronyms MENDS II
- 20 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Jul 2019.
- 20 Jan 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated